Study of SKB107 for advanced cancer with bone tumors
Part of Bones, joints & muscles, Cancer clinical trials.
This trial tests a new drug, SKB107, for people whose advanced cancer has spread to the bones and standard treatments no longer work. The goal is to see if SKB107 can help shrink or slow these bone tumors.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 to 75 years old
- Have advanced cancer that started elsewhere and spread to the bones, confirmed by biopsy or imaging
- Have tried or cannot have standard treatments
- Be well enough to get out of bed and care for yourself (ECOG score 0 or 1)
- Not have had certain other radiation or radionuclide treatments for bone tumors
- Must not have serious heart, liver, or other health problems that could interfere with the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called BPR-6023021 in people with advanced solid tumors that have spread to the bones. The goal is to see if the drug can help control the cancer and improve symptoms.
This study tests an experimental drug called SKB118 in people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if the drug can shrink tumors or slow their growth.
This trial tests a new drug called SKB518 for people with advanced solid tumors that have stopped responding to standard treatments or cannot receive them. The goal is to see if SKB518 can help shrink or control the tumor.
This trial tests a new drug called SKB571 for people with advanced lung cancer that has a specific change in the MET gene. The goal is to see if the drug can shrink tumors or stop them from growing.
This trial tests a new drug called SKB103 for people with advanced solid tumors that have not responded to standard treatments or who cannot tolerate them. The study aims to see if SKB103 is safe and effective.
This trial tests a new drug called SKB105 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug is safe and effective.
Hear when a new Metastatic Solid Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.